C12N 2740/10021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2740/10021 (Viruses as such) appears on 24 US grants and 21 published applications in this corpus.
Search patents in C12N- Granted patents
- 24
- Published applications
- 21
- Assignees
- 20
- Inventors
- 45
- Latest grant
- 30 Aug 2011
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 3 | 0 |
| 1997 | 0 | 0 |
| 1998 | 3 | 0 |
| 1999 | 4 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 2 |
| 2004 | 1 | 4 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 1 |
| 2009 | 1 | 3 |
| 2010 | 2 | 1 |
| 2011 | 2 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Polynucleotide fragments of an infectious human endogenous retrovirus30 Aug 2011US 8,008,460 B2Avir Green Hills Biotechnology Research Development Trade AG
- Human endogenous retrovirus K102 with foamy-virus-like properties and uses thereof21 Jun 2011US 7,964,341 B2
- Endogenous retroviruses up-regulated in prostate cancer17 Aug 2010US 7,776,523 B2Novartis Vaccines and Diagnostics, Inc.
- Nucleic acids obtained from LAVMAL, a variant African AIDS virus3 Aug 2010US 7,767,800 B2Institut Pasteur
- Polynucleotide fragments of an infectious human endogenous retrovirus31 Mar 2009US 7,510,862 B2Avir Green Hills Biotechnology Research Development Trade AG
- Porcine endogenous retrovirus (perv)-free porcine circovirus type 2d-based vaccines and methods of use30 Oct 2025US 2025/0332242 A1Zoetis Services LLC
- Methods of purifying an enveloped virus17 Jul 2025US 2025/0230419 A1CSL Behring GmbH
- Endogenous retrovirus polypeptides linked to oncogenic transformation15 May 2014US 2014/0135384 A1Novartis Vaccines and Diagnostics, Inc.
- Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus20 Sep 2012US 2012/0237527 A1Avir Green Hills Biotechnology Research Development Trade AG
- Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof26 Jan 2012US 2012/0021403 A1
Most cited
By later US patents
- Endogenous retroviruses up-regulated in prostate cancer68US 7,776,523 B2Novartis Vaccines and Diagnostics, Inc. · 2010
- Variant of LAV viruses15US 5,030,714 AInstitut Pasteur · 1991
- Process for the production of a viable cell culture infected by a multiple sclerosis-associated virus14US 5,585,262 ABio Merieux · 1996
- Cell lines and viral isolates associated with multiple sclerosis12US 6,342,383 B12002
- Retrovirus isolated from mantle histiocytes in mantle cell lymphoma12US 6,924,095 B2The Regents of the University of California · 2005